Correction of duplications in the DMD gene by a CRISPR/Cas9 approach

Project Information

DMD2CURE

Grant agreement ID: 703093

DOI 10.3030/703093

Project closed

EC signature date 14 April 2016

Start date 1 March 2017

End date 28 February 2019

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost € 185 076,00

EU contribution € 185 076,00

Coordinated by

ASSOCIATION GENETHON
France

Publications

Peer reviewed articles (1)

Correction of the Exon 2 Duplication in DMD Myoblasts by a Single CRISPR/Cas9 System

Author(s): Annalisa Lattanzi, Stephanie Duguez, Arianna Moiani, Araksya Izmiryan, Elena Barbon, Samia Martin, Kamel Mamchaoui, Vincent Mouly, Francesco Bernardi, Fulvio Mavilio, Matteo Bovolenta
Published in: Molecular Therapy - Nucleic Acids, Issue 7, 2017, Page(s) 11-19, ISSN 2162-2531
Publisher: Nature Publishing Group
DOI: 10.1016/j.omtn.2017.02.004